Loading insider details...
Beta
Latest Form 4 (Sep 26, 2026): Grant/Award of 2,000 NKTR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 26, 2026 | NEKTAR THERAPEUTICS (NKTR) | Grant/Award | 2,000 | n/a |
| Jul 2, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 32,341 | n/a |
| Oct 1, 2025 | NEKTAR THERAPEUTICS (NKTR) | Grant/Award | 8,000 | n/a |
| Jul 2, 2025 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 21,000 | n/a |
| Apr 9, 2025 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 42,000 | n/a |
| May 6, 2024 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 300 | $20.6K |
| Mar 19, 2024 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax Withholding | 22,580 | $1.89M |
| Mar 7, 2024 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale | 4,000 | $348.3K |
| Feb 29, 2024 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 21,440 | n/a |
| Sep 21, 2023 | NEKTAR THERAPEUTICS (NKTR) | Sale | 4,359 | $3.0K |